Literature DB >> 14683552

De novo neurogenesis and acute stroke: are exogenous stem cells really necessary?

John M Abrahams1, Solen Gokhan, Eugene S Flamm, Mark F Mehler.   

Abstract

Recent studies documenting the phenomenon of de novo neurogenesis within the adult brain have propelled this area of research to the forefront of neuroscience investigations and stroke pathogenesis and treatment. Traditional theories have suggested that the central nervous system is incapable of neural regeneration; hence the emergence of the field of stem cell biology as a discipline devoted to uncovering novel forms of neural repair. However, several recent experimental observations have shown that the adult brain is capable of ongoing neurogenesis in discrete regions of the uninjured brain and additional forms of endogenous neural regeneration in the presence of an inciting event (induction neurogenesis). Induction neurogenesis has the potential for providing new insights into the cause and treatment of acute stroke syndromes.

Entities:  

Mesh:

Year:  2004        PMID: 14683552     DOI: 10.1227/01.neu.0000097515.27930.5e

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  13 in total

Review 1.  Cell therapy for stroke.

Authors:  Sean I Savitz; Jonathan H Dinsmore; Lawrence R Wechsler; Daniel M Rosenbaum; Louis R Caplan
Journal:  NeuroRx       Date:  2004-10

2.  Molecular and magnetic resonance imaging of human embryonic stem cell-derived neural stem cell grafts in ischemic rat brain.

Authors:  Marcel M Daadi; Zongjin Li; Ahmet Arac; Brad A Grueter; Marc Sofilos; Robert C Malenka; Joseph C Wu; Gary K Steinberg
Journal:  Mol Ther       Date:  2009-05-12       Impact factor: 11.454

Review 3.  Current status of cell therapies in stroke.

Authors:  Oh Young Bang
Journal:  Int J Stem Cells       Date:  2009-05       Impact factor: 2.500

4.  KAP1 phosphorylation promotes the survival of neural stem cells after ischemia/reperfusion by maintaining the stability of PCNA.

Authors:  Wan Wang; Tianqing Yan; Xinjian Guo; Heng Cai; Chang Liang; Linyan Huang; Yanling Wang; Ping Ma; Suhua Qi
Journal:  Stem Cell Res Ther       Date:  2022-07-07       Impact factor: 8.079

5.  Analysis of neuronal proliferation, migration and differentiation in the postnatal brain using equine infectious anemia virus-based lentiviral vectors.

Authors:  B V Jacquet; M Patel; M Iyengar; H Liang; B Therit; R Salinas-Mondragon; C Lai; J C Olsen; E S Anton; H T Ghashghaei
Journal:  Gene Ther       Date:  2009-05-28       Impact factor: 5.250

6.  Delayed treatment with a p53 inhibitor enhances recovery in stroke brain.

Authors:  Yu Luo; Chi-Chung Kuo; Hui Shen; Jenny Chou; Nigel H Greig; Barry J Hoffer; Yun Wang
Journal:  Ann Neurol       Date:  2009-05       Impact factor: 10.422

7.  Treatment of one case of cerebral palsy combined with posterior visual pathway injury using autologous bone marrow mesenchymal stem cells.

Authors:  Min Li; Aixue Yu; Fangfang Zhang; Guanghui Dai; Hongbin Cheng; Xiaodong Wang; Yihua An
Journal:  J Transl Med       Date:  2012-05-18       Impact factor: 5.531

8.  Cortical neurogenesis in adult rats after ischemic brain injury: most new neurons fail to mature.

Authors:  Qing-Quan Li; Guan-Qun Qiao; Jun Ma; Hong-Wei Fan; Ying-Bin Li
Journal:  Neural Regen Res       Date:  2015-02       Impact factor: 5.135

9.  CART peptide induces neuroregeneration in stroke rats.

Authors:  Yu Luo; Hui Shen; Hua-Shan Liu; Seong-Jin Yu; David J Reiner; Brandon K Harvey; Barry J Hoffer; Yihong Yang; Yun Wang
Journal:  J Cereb Blood Flow Metab       Date:  2012-12-05       Impact factor: 6.200

10.  Intravenous transplantation of mesenchymal stem cells preconditioned with early phase stroke serum: current evidence and study protocol for a randomized trial.

Authors:  Suk Jae Kim; Gyeong Joon Moon; Won Hyuk Chang; Yun-Hee Kim; Oh Young Bang
Journal:  Trials       Date:  2013-10-01       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.